Clinical trial
Pupillographie Als Screeningtest für Cerebrale Insulinresistenz
NCT03651661 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pupillographie Als Screeningtest für Cerebrale Insulinresistenz
- Lead sponsor
- University Hospital Tuebingen
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 3, 2018
- Completion date
- January 7, 2019
- Enrollment
- 22 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.